‘Palliative sedation’? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit

Abstract

Background:

Sedatives are frequently used towards the end of life. However, there is scarce information when their use is labelled as ‘palliative sedation’.

Aim:

To assess the use and labelling of ‘continuous administration of sedatives within the last 7 days of life’, based on objective operational criteria, on a palliative care unit.

Design:

Retrospective cohort study, using medical records. Explorative statistical analysis (SPSS 23).

Setting/participants:

Patients who died on a palliative care unit from August 2014 to July 2015. Sedatives recorded were benzodiazepines, levomepromazine, haloperidol ⩾5 mg/day and propofol.

Results:

Of the 192 patients, 149 (78%) patients received continuous sedatives within the last week of life. The prevalence of delirium/agitation was significantly higher in patients with continuous sedatives compared to those without continuous sedatives at admission to the unit (35% vs 16%, p = 0.02) and on the day before death (58% vs 40%, p = 0.04). The term ‘(palliative) sedation’ was used in the records for 22 of 149 (15%) patients with continuous sedatives. These patients had significantly higher total daily midazolam doses 2 days before death (median (range), 15.0 (6.0–185.0) mg vs 11.5 (1.0–70.0) mg, p = 0.04) and on the day of death (median (range), 19.5 (7.5–240.0) mg vs 12.5 (2.0–65.0) mg, p = 0.01). The dose range was large in both groups.

Conclusion:

The prevalence of delirium/agitation was associated with the administration of continuous sedatives. There was no consistent pattern regarding labelling the use of continuous sedatives as ‘(palliative) sedation’. Multicentre mixed-methods research is needed for a better characterization of sedation practices in palliative care.

Keywords

Sedation palliative sedation hypnotics and sedatives palliative care cohort study benzodiazepines

Get full access to this article

View all access options for this article.

References

de Graeff

Dean

. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007; 10: 67–85.

Dean

Cellarius

Henry

et al . Framework for continuous palliative sedation therapy in Canada. J Palliat Med 2012; 15: 870–879.

Cherny

Radbruch

European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581–593.

Muller-Busch

Andres

Jehser

Sedation in palliative care – a critical analysis of 7 years experience. BMC Palliat Care 2003; 2: 2.

Jaspers

Nauck

Lindena

et al . Palliative sedation in Germany: how much do we know? A prospective survey. J Palliat Med 2012; 15: 672–680.

Klosa

Klein

Heckel

et al . The EAPC framework on palliative sedation and clinical practice – a questionnaire-based survey in Germany. Support Care Cancer 2014; 22: 2621–2628.

Schildmann

Dahmen

Vollmann

Ärztliche Handlungspraxis am Lebensende. Dtsch Med Wochenschr 2015; 140: e1–e6.

Maltoni

Scarpi

Rosati

et al . Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 2012; 30: 1378–1383.

Beller

van Driel

McGregor

et al . Palliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev 2015; 1: CD010206.

10.

Bosshard

Zellweger

Bopp

et al . Medical end-of-life practices in Switzerland: a comparison of 2001 and 2013. JAMA Intern Med 2016; 176: 555–556.

11.

Van der Heide

van Delden

JJM

Onwuteaka-Philipsen

. End-of-life decisions in the Netherlands over 25 years. N Engl J Med 2017; 377: 492–494.

12.

Hopprich

Gunther

Laufenberg-Feldmann

et al . Palliative sedation at a university palliative care unit – a descriptive analysis. Dtsch Med Wochenschr 2016; 141: e60–e61.

13.

Schur

Weixler

Gabl

et al . Sedation at the end of life – a nation-wide study in palliative care units in Austria. BMC Palliat Care 2016; 15: 50.

14.

Papavasiliou

Brearley

Seymour

et al . From sedation to continuous sedation until death: how has the conceptual basis of sedation in end-of-life care changed over time? J Pain Symptom Manage 2013; 46: 691–706.

15.

Morita

Differences in physician-reported practice in palliative sedation therapy. Support Care Cancer 2004; 12: 584–592.

16.

Seymour

Rietjens

Bruinsma

et al . Using continuous sedation until death for cancer patients: a qualitative interview study of physicians’ and nurses’ practice in three European countries. Palliat Med 2015; 29: 48–59.

17.

Rietjens

JAC

van Zuylen

van Veluw

et al . Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008; 36: 228–234.

18.

Miccinesi

Rietjens

Deliens

et al . Continuous deep sedation: physicians’ experiences in six European countries. J Pain Symptom Manage 2006; 31: 122–129.

19.

Robijn

Cohen

Rietjens

et al . Trends in continuous deep sedation until death between2007 and 2013: a repeated nationwide survey. PLoS ONE 2016; 11: e0158188.

20.

Rietjens

Buiting

Pasman

et al . Deciding about continuous deep sedation: physicians’ perspectives: a focus group study. Palliat Med 2009; 23: 410–417.

21.

Alt-Epping

Nauck

Jaspers

Was ist das Problematische an der Palliativen Sedierung? – eine Übersicht. Ethik Med 2015; 3: 219–231.

22.

Morita

Maeda

Mori

et al . Uniform definition of continuous-deep sedation. Lancet Oncol 2016; 17: e222.

23.

Morita

Imai

Yokomichi

et al . Continuous deep sedation: a proposal for performing more rigorous empirical research. J Pain Symptom Manage 2017; 53: 146–152.

24.

Schildmann

Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med 2014; 17: 601–611.

25.

Schildmann

Kiesewetter

Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines. J Pain Symptom Manage 2015; 49: 734–746.

26.

Abarshi

Rietjens

Robijn

et al . International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care 2017; 7: 223–229.

27.

Gurschick

Mayer

Hanson

LC.

Palliative sedation: an analysis of international guidelines and position statements. Am J Hosp Palliat Care 2015; 32: 660–671.

28.

Stiel

Krumm

Schroers

et al . Indications and use of benzodiazepines in a palliative care unit. Schmerz 2008; 22: 665–671.

29.

Maiser

Estrada-Stephen

Sahr

et al . A survey of hospice and palliative care clinician’s experiences and attitudes regarding the use of palliative sedation. J Palliat Med 2017; 20: 915–921.

30.

Sykes

Thorns

Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003; 163: 341–344.

31.

Stone

Phillips

Spruyt

et al . A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997; 11: 140–144.

32.

Morita

Bito

Kurihara

et al . Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 2005; 8: 716–729.

33.

Remi

Bausewein

Twycross

et al . Arzneimitteltherapie in der Palliativmedizin. München: Urban & Fischer, 2015.

34.

Watson

Lucas

Hoy

et al . Oxford handbook of palliative care, 2nd ed. Oxford: Oxford University Press, 2009.

35.

Twycross

Wilcock

Howard

Palliativedrugs.com Ltd, www.palliativedrugs.com (accessed 8 July 2014).

36.

Kirk

Mahon

MM.

National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage 2010; 39: 914–923.

37.

Schildmann

Groeneveld

Denzel

et al . Discovering the hidden benefits of cognitive interviewing in two languages: the first phase of a validation study of the integrated palliative care outcome scale. Palliat Med 2016; 30: 599–610.

38.

Abernethy

Shelby-James

Fazekas

et al . The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care 2005; 4: 7.

39.

Onwuteaka-Philipsen

Brinkman-Stoppelenburg

Penning

et al . Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from1990 to 2010: a repeated cross-sectional survey. Lancet 2012; 380: 908–915.

40.

Bozzaro

The concept of suffering in medicine: an investigation using the example of deep palliative sedation at the end of life. Ethik Med 2015; 2015: 1–14.